Ruxolitinib for refractory large granular lymphocyte leukemia
Domaines
Cancer
Fichier principal
Moignet et al-2021-Ruxolitinib for refractory LGL leukemia.pdf (794.6 Ko)
Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Commentaire : Data available on request from the authors: The data that support the findings of this study are available from the corresponding author upon reasonable request.
Commentaire : Data available on request from the authors: The data that support the findings of this study are available from the corresponding author upon reasonable request.